We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
-12.74%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$9.71B
AUM Growth
-$2.06B
Cap. Flow
-$337M
Cap. Flow %
-3.47%
Top 10 Hldgs %
9.27%
Holding
1,014
New
56
Increased
328
Reduced
391
Closed
79

Top Buys

Rank Stock Value
1
IAA
IAA, Inc. Common Stock
IAA
+$44.6M
2
ESAB icon
ESAB
ESAB
+$38.2M
3
ZD icon
Ziff Davis
ZD
+$28.5M
4
CABO icon
Cable One
CABO
+$19.3M
5
AL
Air Lease Corp
AL
+$18.9M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.04%
3 Consumer Discretionary 13.73%
4 Financials 13.51%
5 Materials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
526
Halozyme
HALO
$12.1B
$4.22M 0.04%
96,000
+64,000
+200% +$2.77M
RNGR icon
527
Ranger Energy Services
RNGR
$394M
$4.22M 0.04%
416,490
RJET
528
Republic Airways Holdings
RJET
$817M
$4.2M 0.04%
127,746
+2,434
+2% +$114K
GTLS
529
DELISTED
Chart Industries
GTLS
$4.18M 0.04%
25,000
+5,000
+25% +$854K
HLIT icon
530
Harmonic Inc
HLIT
$1.27B
$4.16M 0.04%
480,100
+74,600
+18% +$672K
ONTF
531
DELISTED
ON24
ONTF
$4.13M 0.04%
435,700
ATRC icon
532
AtriCure
ATRC
$2.86B
$4.13M 0.04%
100,982
-400
-0.4% -$18.9K
STAA icon
533
STAAR Surgical
STAA
$1.13B
$4.11M 0.04%
57,984
+2,039
+4% +$131K
GNSS icon
534
Genasys
GNSS
$67.9M
$4.09M 0.04%
1,259,493
-30,600
-2% -$98.2K
ACU icon
535
Acme United Corp
ACU
$235M
$4.08M 0.04%
128,677
-800
-0.6% -$26K
SLAB icon
536
Silicon Laboratories
SLAB
$7.34B
$4.07M 0.04%
29,000
+5,000
+21% +$700K
QTRX icon
537
Quanterix
QTRX
$129M
$4.06M 0.04%
250,748
+19,200
+8% +$395K
COHR icon
538
Coherent
COHR
$53.1B
$4.06M 0.04%
79,612
-295
-0.4% -$18K
CSCO icon
539
Cisco
CSCO
$434B
$4.01M 0.04%
94,000
+9,000
+11% +$431K
ABTX
540
DELISTED
Allegiance Bancshares
ABTX
$4M 0.04%
105,907
-700
-0.7% -$28.1K
ADNT icon
541
Adient
ADNT
$1.42B
$3.98M 0.04%
134,200
+9,200
+7% +$309K
PBH icon
542
Prestige Consumer Healthcare
PBH
$2.21B
$3.95M 0.04%
67,165
-5,736
-8% -$316K
NTUS
543
DELISTED
Natus Medical Inc
NTUS
$3.95M 0.04%
120,457
-240,401
-67% -$7.6M
PFBC icon
544
Preferred Bank
PFBC
$1.25B
$3.94M 0.04%
58,000
-1,194
-2% -$81.7K
CCF
545
DELISTED
Chase Corporation
CCF
$3.94M 0.04%
50,586
+66
+0.1% +$5.41K
GPC icon
546
Genuine Parts
GPC
$18.1B
$3.92M 0.04%
29,500
+2,000
+7% +$266K
GHM icon
547
Graham Corp
GHM
$982M
$3.91M 0.04%
564,827
-20,124
-3% -$152K
MGPI icon
548
MGP Ingredients
MGPI
$308M
$3.9M 0.04%
39,000
+19,000
+95% +$1.79M
USAP
549
DELISTED
Universal Stainless & Alloy
USAP
$3.89M 0.04%
525,587
-3,400
-0.6% -$27.4K
NPKI
550
NPK International
NPKI
$1.1B
$3.88M 0.04%
1,256,400
-19,300
-2% -$73.9K

Similar funds

Royce & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Royce & Associates held 1,014 positions worth $9.71B, down 18% from $11.8B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Royce & Associates withdrew a net $337M in Q2 2022, closing 79 positions and reducing 391 holdings. Its most notable exit was Shift4, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in ESAB worth $34.7M.

  • Royce & Associates's largest Q2 2022 buy was ESAB: 792,263 shares worth $34.7M.
  • Royce & Associates added most to IAA, Inc. Common Stock in Q2 2022, an estimated $44.6M increase.
  • Royce & Associates's biggest Q2 2022 reduction was Alleghany Corp, cutting an estimated $40.8M.
  • Royce & Associates fully exited Shift4 in Q2 2022, selling an estimated $36.2M.
  • Royce & Associates's ten largest holdings make up 9.3% of its $9.71B portfolio in Q2 2022.
  • Royce & Associates opened 56 new positions and closed 79 in Q2 2022.
  • Royce & Associates's portfolio value fell 18% quarter-over-quarter to $9.71B.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.